The role of implantable sensors for management of heart failure

Studies in Health Technology and Informatics

Volumn 108, Issue , 2005, Pages 219-227

  Kadhiresan, Kadir ^a   Carlson, Gerrard ^a  

^a BOSTON SCIENTIFIC CORPORATION   (United States)

Author keywords

bi ventricular pacing; cardiac resynchronization; Heart failure; heart rate variability; sensors

Indexed keywords

DIAGNOSIS; DISEASES; HEART; IMPLANTS (SURGICAL); PATIENT MONITORING; PATIENT TREATMENT; SENSORS; WEARABLE TECHNOLOGY;

CARDIAC RESYNCHRONIZATION; CARDIAC RESYNCHRONIZATION THERAPY (CRT); CONTINUOUS MONITORING; HEART FAILURE; HEART RATE INTERVALS; HEART RATE VARIABILITY; IMPLANTABLE DEVICES; VENTRICULAR PACING;

CARDIAC RESYNCHRONIZATION THERAPY;

AMBULATORY MONITORING; ARTIFICIAL HEART PACEMAKER; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; GENETIC PROCEDURES; HEART RATE; HUMAN; INSTRUMENTATION; METHODOLOGY; PROSTHESES AND ORTHOSES; REVIEW; RISK ASSESSMENT;

BIOSENSING TECHNIQUES; CLINICAL TRIALS; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; MONITORING, AMBULATORY; PACEMAKER, ARTIFICIAL; PROSTHESES AND IMPLANTS; RISK ASSESSMENT;

EID: 14844309698     PISSN: 09269630     EISSN: 18798365     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (21)

1. Heart and Stroke Statistical Update. . Dallas, TX: American Heart Association; 2003
2. O'Connell JB, Bristow MR: Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant 13: S107-S112, 1994.
3. Cleland JE European Heart Journal (2001) 22, 623-626
4. Ho KKL, Anderson K M, Kannel WB, et al. : Survival after the onset of congestive heart failure in the Framingham Heart Study Subjects. Circulation 1993, 88: 107-115
5. Houghton AR, Harrison M, Cowley AJ, Hampton JR. Assessing exercise capacity, quality of life and haemodynamics in heart failure: do the tests tell us the same thing? Eur J Heart Fail. 2002 Jun;4(3):289-95
6. Sherman WM, Morris DM, Kirby TE, Petosa RA, Smith BA, Frid DJ, Leenders N Evaluation of a commercial accelerometer (Tritrac-R3 D) to measure energy expenditure during ambulation Int J Sports Med. 1998 Jan;19(1):43-7
7. Wilhelm FH, RothWT, Sackner MA The lifeShirt. An advanced system for ambulatory measurement of respiratory and cardiac function Behav Modif. Oct;27(5):671-91, 2003.
8. Bradley DJ, Bradley EA, Baughman KL, Berger RD, Calkins H, Goodman SN, Kass DA, and Powe NR. Cardiac Resynchronization and Death From Progressive Heart Failure: A Metaanalysis of Randomized Controlled Trials. JAMA 289: 730-740., 2003
9. Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW, Berman LB. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985;132:919-923.
10. System Guide CONTAK R- RENEWALTM3. Guidant Corporation.
11. Auricchio A et al. Long-Term Clinical Effect of Hemodynamically Optimized Cardiac Resynchronization Therapy in Patient With Heart Failure and Ventricular Conduction Delay JACC Vol. 39, No. 12, 2002.
12. Philip B. Adamson, MD; Karen J. Kleckner, MS; Warren L. VanHout, BSEE; Sriram Srinivasan, MS; William T. Abraham, MD. Cardiac Resynchronization Therapy Improves Heart Rate Variability in Patients with Symptomatic Heart Failure, Circulation. 2003;108:266-269.
13. Nolan J, Batin, PD, Andrews, R. Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure, Circulation. 98:1510-1516, 1998
14. Carlson G, Girouard, S, Schlegl, M, Butter, C. Three dimensional heart rate variability diagnostic to monior heart failure through an implantable device. Journal of Cardiovascular Electrophysiology, In Press 2004.
15. G Carlson, A Auricchio, S Sack, V Kadhiresan,WHorsch, UMichel, J Spinelli for the PATHCHF Investigators, CPI/Guidant, St. Paul,MN, Prediction of Exercise Capacity in Heart Failure Patients During Pacing Therapy Using a New 2-D Heart Rate Variability Parameter, Journal of Cardiac Failure, Volume 4, Number 3, page 32, Supplement 1 1998, Abstract 120. and Circulation Volume 98 Number 17, page I-302, Supplement I, Abstract 1580.
16. Goldsmith RL, Bigger JT Jr, Steinman RC: Physical fitness level is an important determinant of parasympathetic nervous system activity in studies using heart period variability. Circulation 88:I115, 1993.
17. Yi G, Goldman JH, Keeling PJ, Reardon M, McKenna WJ, Malik M., Heart rate variability in idiopathic dilated cardiomyopathy: relation to disease severity and prognosis. Heart 1997 Feb;77(2):108-14
18. Floras J et al. Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. JACC (22) 72A - 84A, 1993
19. Cohn J et al. Plasma norepinephrine as a guide to prognosis in patients with congestive heart failure. N Engl J Med;311:819-23,1984
20. ACC Guidelines on ambulatory Electrocardiography Part III. JACC Vol. 34, Part 3, 912-948, 1999
21. Binkley et al. Parasympathetic withdrawal is an integral component of autonomic imbalance in Congestive Heart Failure: Demonstration in Human Subjects and Verification in a Paced Canine Model of Ventricular Failure. JACC; 464-472, 1991